VENTURE CAPITAL

COMPANY

AMOUNT/ROUND

LEAD INVESTORS

DESCRIPTION

Zogenix
San Diego

$60M
First

Clarus Ventures and Domain Associates

The company's initial focus is the completion of the late-stage development and commercialization of Intraject sumatriptan.

Codexis
Redwood City, CA

$37M
Fourth

Bio*One Capital

Much of the money will go to financing a new research and development arm in Singapore that will support its work in generics.

Medior
Malvern Hill, PA

$7M
First

Polaris Ventures and Morgenthaler Ventures

Medior is developing therapeutics for the treatment of fibrotic disorders and diseases.